Modern possibilities of using immunotherapy in the treatment of cervical cancer

Cervical cancer (CC) is the fourth most common cancer in women worldwide. Every year, more than 500,000 women are diagnosed with CC, and the disease leads to more than 300,000 deaths worldwide. Infection with the human papillomavirus is the cause of CC in most cases. The disease is largely preventab...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: A. V. Tarasova, K. A. Ganina, M. A. Meshkova, Yu. V. Solovyeva, E. E. Ivanova, L. N. Akimov
Materialtyp: Artigo
Språk:Russo
Publicerad: ABV-press 2021-09-01
Serie:Opuholi Ženskoj Reproduktivnoj Sistemy
Ämnen:
immunotherapy
pembrolizumab
nivolumab
pd-1
pd-l1
biomarkers
Länkar:https://ojrs.abvpress.ru/ojrs/article/view/851
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk